Mind Medicine (MindMed) Inc. (MNMD:NASDAQ) closed at $15.02 on January 14, 2026, up 1.01% on the day. The stock trades 17.1% below its 52-week high of $18.12 and 219.6% above its 52-week low of $4.70. Mind Medicine (MindMed) Inc. is part of the Health Care sector.
In 252 trading sessions since October 22, 2025, MNMD closed higher on 34 days (13%). Its best day was January 20, 2026 (+11.50%) and its worst was January 26, 2026 (-13.68%). The stock moved 10% or more in a single session 4 times.
Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.
Find more stocks like MNMD with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.